Based, Babraham Research Campus, Cambridge, Salary dependent on experience

Cancer Research Technology (CRT), a wholly owned subsidiary of Cancer Research UK, is a vibrant drug discovery and commercialisation company which aims to advance new discoveries to beat cancer. To help achieve this goal CRT has its own drug discovery laboratories, CRTDL, based at locations in Central London and Cambridge.

CRTDL is dedicated to helping cancer patients through establishing and prosecuting theme-based alliances with industry. We collaborate with the academic community and our commercial partners to discover and develop novel cancer therapies. Our pioneering model has already resulted in cancer drug discovery alliances with major international partners including AstraZeneca, Forma Therapeutics and Teva Pharmaceuticals.

This laboratory-based position at senior scientist level is required within CRTDL’s Discovery Bioscience team.

This role provides an opportunity to take responsibility for the optimisation and execution of high throughput cellular screening to support chemical biology approaches to emerging areas of cancer biology. The successful candidate will be proficient in the use of cell culture and in the use of automation for cell-based assays, and will have experience in developing cancer relevant phenotypic assays using cellular imaging and other endpoints.  An ability to curate, store and retrieve large datasets, and familiarity with multi-dimensional data and statistical analysis of complex data sets is desirable.

To apply, please send a copy of your CV and a covering letter, quoting the reference number DBS015, by email to crtrecruitment@cancertechnology.com specifying which role you are applying to.

Closing Date: Friday 30th January 2015

Please note that applications will only be accepted from candidates who have proof of their right to work in the UK.